Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria VaccineDaniel E. Neafsey, Carsten Russ, Dyann F. Wirth et al.|New England Journal of Medicine|2015Cited by 451
Effect of monthly intermittent preventive treatment with dihydroartemisinin–piperaquine with and without azithromycin versus monthly sulfadoxine–pyrimethamine on adverse pregnancy outcomes in Africa: a double-blind randomised, partly placebo-controlled trialMwayiwawo Madanitsa, Feiko O. ter Kuile, Hellen C. Barsosio et al.|The Lancet|2023Cited by 72
Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin–piperaquine in pregnant women living with HIV on daily co-trimoxazole in Kenya and Malawi: a randomised, double-blind, placebo-controlled trialHellen C. Barsosio, Feiko O. ter Kuile, Mwayiwawo Madanitsa et al.|The Lancet|2024Cited by 21
Performance of a rapid antigen test for SARS-CoV-2 in KenyaSimon Onsongo, Tobias F. Rinke de Wit, Kephas Otieno et al.|Diagnostic Microbiology and Infectious Disease|2021Cited by 20
Public-private partnership to rapidly strengthen and scale COVID-19 response in Western KenyaShannen van Duijn, Tobias F. Rinke de Wit, Hellen C. Barsosio et al.|Frontiers in Public Health|2023Cited by 10